Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Microglia and Their Regulation in Parkinson’s Disease
Weidong Le, Junjiao Wu, Yu Tang
Frontiers in Molecular Neuroscience (2016) Vol. 9
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Benjamin G. Trist, Dominic J. Hare, Kay L. Double
Aging Cell (2019) Vol. 18, Iss. 6
Open Access | Times Cited: 575
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Marta Pajares, Ana I. Rojo, Gina Manda, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1687-1687
Open Access | Times Cited: 557
The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
Ana I. Ramı́rez, Rosa de Hoz, Elena Salobrar‐García, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 397
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
Sarah E. Corcoran, Reena Halai, Matthew A. Cooper
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 968-1000
Open Access | Times Cited: 116
Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
Jinming Han, Violeta Chiţu, E. Richard Stanley, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 4
Open Access | Times Cited: 98
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Bruna Araújo, Rita Caridade-Silva, Carla Guedes, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2908-2908
Open Access | Times Cited: 85
The reciprocal interactions between microglia and T cells in Parkinson’s disease: a double-edged sword
Yuxiang Xu, Yongjie Li, Changqing Wang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
Paulina Troncoso-Escudero, Alejandra V. Parra, Melissa Nassif, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 156
Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
Cynthia Lecours, Maude Bordeleau, Léo Cantin, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 137
An updated assessment of microglia depletion: current concepts and future directions
Jinming Han, Robert A. Harris, Xing‐Mei Zhang
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 131
Microglial Activation in the Pathogenesis of Huntington’s Disease
Huiming Yang, Su Yang, Shanshan Huang, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 121
Heat-Shock Proteins in Neuroinflammation
Brigitta Dukay, Bálint Csoboz, Melinda Tóth
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 105
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
José Fidel Baizabal‐Carvallo, Marlene Alonso-Juárez
Neuroscience (2020) Vol. 432, pp. 160-173
Closed Access | Times Cited: 98
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
Felipe Patricio, Alan Axel Morales-Andrade, Aleidy Patricio-Martínez, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 97
Non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease in the elderly population: a meta-analysis
Tahmina Nasrin Poly, Md. Mohaimenul Islam, Hsuan‐Chia Yang, et al.
European Journal of Clinical Pharmacology (2018) Vol. 75, Iss. 1, pp. 99-108
Closed Access | Times Cited: 96
Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management
Ramandeep Kaur, Sidharth Mehan, Shamsher Singh
Neurological Sciences (2018) Vol. 40, Iss. 1, pp. 13-23
Open Access | Times Cited: 89
A systematic review of minor phytocannabinoids with promising neuroprotective potential
Nicole L. Stone, Alexandra J. Murphy, Timothy J. England, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 19, pp. 4330-4352
Open Access | Times Cited: 86
The cannabinoid system and microglia in health and disease
Samuel S. Duffy, Jessica P. Hayes, Nathan T. Fiore, et al.
Neuropharmacology (2021) Vol. 190, pp. 108555-108555
Closed Access | Times Cited: 71
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Shuanglong Yi, Linfang Wang, Honglei Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14753-14753
Open Access | Times Cited: 41
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Limonene, a Monoterpene, Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Modulating Neuroinflammation, Hippo Signaling and Apoptosis in Rats
Lujain Bader Eddin, Sheikh Azimullah, Niraj Kumar Jha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5222-5222
Open Access | Times Cited: 22
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 22
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Alexander Hull, Magda L. Atilano, Laith Gergi, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 12
Functional and Therapeutic Potential of Cynara scolymus in Health Benefits
Chiara Porro, Tarek Benameur, Antonia Cianciulli, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 872-872
Open Access | Times Cited: 10
TREM2 deficiency aggravates α‐synuclein–induced neurodegeneration and neuroinflammation in Parkinson's disease models
Ying Guo, Xinbing Wei, Hua Yan, et al.
The FASEB Journal (2019) Vol. 33, Iss. 11, pp. 12164-12174
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top